Proleukin
Term · Oncology and biomedicine · MLC-T-ONC-006955
A drug used to treat adults with melanoma or renal cell carcinoma (a type of kidney cancer) that has spread to other parts of the body. It is also being studied in the treatment of other types of cancer. Proleukin is a form of interleukin-2 that is made in the laboratory. Proleukin increases the activity and growth of white blood cells called T lymphocytes and B lymphocytes, which may help the immune system kill cancer cells. Proleukin is a type of cytokine and a type of immunomodulating agent. Also called aldesleukin and recombinant human interleukin-2.
| Identifier | MLC-T-ONC-006955 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | aldesleukin; recombinant human interleukin-2 |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-006955",
"term": "Proleukin",
"field": "Oncology and biomedicine",
"definition": "A drug used to treat adults with melanoma or renal cell carcinoma (a type of kidney cancer) that has spread to other parts of the body. It is also being studied in the treatment of other types of cancer. Proleukin is a form of interleukin-2 that is made in the laboratory. Proleukin increases the activity and growth of white blood cells called T lymphocytes and B lymphocytes, which may help the immune system kill cancer cells. Proleukin is a type of cytokine and a type of immunomodulating agent. Also called aldesleukin and recombinant human interleukin-2.",
"synonyms": [
"aldesleukin",
"recombinant human interleukin-2"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/proleukin/"
}
Record 13,685 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.